At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Biocreative therapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Labial Versus Lingual Biocreative Therapy for en Masse Retraction of Maxillary Anterior Teeth: A Randomized Clinical Trial
In Brief
A clinical study evaluating Biocreative therapy for Malocclusion, Angle Class II, Division 1. Completed, enrolled 30 participants.
Detailed Summary
The purpose of this study is to compare the effectiveness and efficiency of labial versus lingual biocreative therapy in achieving en masse retraction of the maxillary anterior teeth in subjects with class II malocclusion requiring upper first premolar extraction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalocclusion, Angle Class II, Division 1
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedAug 2017
Primary CompletionApr 2018
Study CompletionSep 2018
TodayJul 2026
First PostedAug 4, 2017
Enrollment StartJan 17, 2016
Primary CompletionApr 30, 2018
Study CompletionSep 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 8.9 years ago
Interventions
Biocreative therapyprocedure